Drug Shortage Report for TRIESENCE

Last updated on 2019-09-25 History
Report ID 83368
Drug Identification Number 02368676
Brand name TRIESENCE
Common or Proper name TRIESENCE 1ML SUSP X12
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAVITREAL
Packaging size 12
ATC code S01BA
ATC description ANTIINFLAMMATORY AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-06-03
Actual start date 2019-05-27
Estimated end date 2020-03-31
Actual end date
Shortage status Actual shortage
Updated date 2019-09-25
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2019-09-25 French Compare
v12 2019-09-25 English Compare
v11 2019-08-12 French Compare
v10 2019-08-12 English Compare
v9 2019-06-04 French Compare
v8 2019-06-04 English Compare
v7 2019-06-04 English Compare
v6 2019-05-10 French Compare
v5 2019-05-10 English Compare
v4 2019-05-10 French Compare
v3 2019-05-10 English Compare
v2 2019-05-07 French Compare
v1 2019-05-07 English Compare